Your browser doesn't support javascript.
loading
Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study).
Akechi, Tatsuo; Yamaguchi, Takuhiro; Uchida, Megumi; Imai, Fuminobu; Momino, Kanae; Katsuki, Fujika; Sakurai, Naomi; Miyaji, Tempei; Mashiko, Tomoe; Horikoshi, Masaru; Furukawa, Toshi A; Yoshimura, Akiyo; Ohno, Shinji; Uehiro, Natsue; Higaki, Kenji; Hasegawa, Yoshie; Akahane, Kazuhisa; Uchitomi, Yosuke; Iwata, Hiroji.
Afiliación
  • Akechi T; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Yamaguchi T; Division of Palliative Care and Psycho-oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Uchida M; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Imai F; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Momino K; Division of Palliative Care and Psycho-oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Katsuki F; Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Sakurai N; Division of Palliative Care and Psycho-oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Miyaji T; Department of Nursing Administration and Management, Nagoya City University Graduate School of Nursing, Nagoya, Japan.
  • Mashiko T; Department of Psychiatric and Mental Health Nursing, Nagoya City University Graduate School of Nursing, Nagoya, Japan.
  • Horikoshi M; Cancer Solutions Co, Ltd, Tokyo, Japan.
  • Furukawa TA; Department of Clinical Trial Data Management, Tokyo University Graduate School of Medicine, Tokyo, Japan.
  • Yoshimura A; Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo, Japan.
  • Ohno S; Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
  • Uehiro N; National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Higaki K; Kyoto University Graduate School of Medicine/School of Public Health, Department of Health Promotion of Human Behavior, Kyoto, Japan.
  • Hasegawa Y; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Akahane K; Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Uchitomi Y; Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Iwata H; Higaki Breast Clinic, Hiroshima, Japan.
J Clin Oncol ; 41(5): 1069-1078, 2023 02 10.
Article en En | MEDLINE | ID: mdl-36322882
ABSTRACT

PURPOSE:

Fear of cancer recurrence (FCR) is a common distressing condition. We investigated the efficacy of smartphone problem-solving therapy and behavioral activation applications in breast cancer survivors.

METHODS:

This was a decentralized randomized trial. Participants were disease-free breast cancer survivors age 20-49 years who were randomly assigned to the smartphone-based intervention or waitlist control. Both groups received treatment as usual. The control group could access the smartphone apps during weeks 8-24. The intervention comprised smartphone problem-solving therapy and behavioral activation apps. The primary end point was the Concerns About Recurrence Scale at week 8. Secondary outcomes included the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF), the Hospital Anxiety and Depression Scale (HADS), the Short-form Supportive Care Needs Survey (SCNS-SF34), and the Posttraumatic Growth Inventory at weeks 8 and 24 (trial registration UMIN-CTR UMIN000031140).

RESULTS:

The intervention group included 223 participants, and the control group included 224 participants. Primary outcome data were obtained for 444 participants, and 213 participants in the intervention arm completed the week 24 assessment. The intervention group had statistically greater improvements than controls at week 8 on the Concerns About Recurrence Scale (difference -1.39; 95% CI, -1.93 to -0.85; P < .001), FCRI-SF (difference -1.65; 95% CI, -2.41 to -0.89; P < .001), HADS depression (difference -0.49; 95% CI, -0.98 to 0; P < .05), and SCNS-SF34 psychological domain (difference -1.49; 95% CI, -2.67 to -0.32; P < .05). These scores at week 24 were not statistically significant compared with week 8 although the HADS depression score at week 24 was significantly reduced (P = .03).

CONCLUSION:

Novel smartphone psychotherapy offers a promising way to reduce FCR given the large number of survivors and a limited number of therapists to competently conduct psychotherapy.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Supervivientes de Cáncer Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Supervivientes de Cáncer Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón